• Affiliate Instructor, Global Health

Makerere University
Infectious Diseases Institute Kasangati
Box 22418

Phone Number: 
Select from the following:

Andrew Mujugira, MBChB, PhD is head of the Infectious Diseases Institute Kasangati, Makerere University, Uganda. He has ten years of experience with PrEP efficacy trials, demonstration projects and implementation studies. His current research focuses on combining HIV prevention tools (HIV self-testing, antiretroviral therapy and PrEP) to build self-efficacy and empowerment, increase antiretroviral adherence and reduce sexual risk behaviors among key populations in Uganda.

  • MBChB (Makerere University)
  • MS (University of London (UK))
Country Affiliations 
  • Luganda
  • Runyankore
Health Topics 
  • Prevention
  • Research
DGH Centers, Programs and Initiatives and Affiliated Organizations 

Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odody J, Tindiwembwa E, Bulya N, Katabira E, Heffron R. High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy. AIDS Res Hum Retroviruses. 2017 Sept 13.

Mujugira A, Celum C, Ngure K, Thomas KK, Katabira E, Baeten JM; Partners PrEP Study Team. Antiretroviral Therapy is Not Associated With Risky Sexual Behavior Among Heterosexual HIV-Infected Persons in Serodiscordant Partnerships. Sex Trans Dis. 2017 Jan;44(1):57-61.

Mujugira A, Celum C, Coombs RW, Campbell JD, Ndase P, Ronald A, Were E, Bukusi EA, Mugo N, Kiarie J, Baeten JM. HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy. J Acquir Defic Syndr. 2016 Apr 6.

Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, Baeten JM; Partners PrEP Study Team. Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy. J Infect Dis. 2016 Apr 6.

Mujugira A, Celum C, Tappero JW, Ronald A, Mugo N, Baeten JM. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1 Infected Persons in Serodiscordant Partnerships. AIDS Res Hum Retroviruses. 2016 Feb;32(2):148-54.